{"ok":true,"article":{"slug":"opinion-the-cancer-vaccine-interrupts-a-technology-backlash-9d3f9bb2","title":"Opinion | The cancer vaccine interrupts a technology backlash","url":"https://news.google.com/rss/articles/CBMingFBVV95cUxOcnlHcUZSUVk3UXU4dTZxeWdHb3FTOTJ3TUphRG1RMExIQWxBTDhqaF9YVTM4NXdheTlZSG4xNmk2SVVsUzhhTERnWFBNUi01QVJKWGdkdk45dWdQT0VOTkROLXJVbWdiNjVaLXp2TFAxNVZiNEt3WkZHRjZqV25ScFVqeDVSdTMtdUliaGhWTXRRSXRXSXB4ZGhPSlhJQQ?oc=5&hl=en-US&gl=US&ceid=US:en","canonical":"https://www.aimode.news/article/opinion-the-cancer-vaccine-interrupts-a-technology-backlash-9d3f9bb2","sourceName":"The Washington Post","summary":"Related coverage: Opinion | The cancer vaccine interrupts a technology backlash The Washington Post Cancer vaccine from Moderna, Merck shows promise in late-stage trial; both stocks soar CNBC Moderna’s 177% Surge Burns Shorts in ‘Painful’ $5.5 Billion Loss Bloomberg Moderna’s Shift to Cancer Company Lifts Stock Up 177% The New York Times Moderna, Merck breakthrough could usher in wave of cancer vaccines Reuters","category":"Business","image":null,"lang":"en","publishedAt":"2026-08-21T00:38:49+00:00","createdAt":"2026-08-21T01:00:13.499778+00:00"}}